NEUROBLASTOMA RECURRENT
Clinical trials for NEUROBLASTOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new NEUROBLASTOMA RECURRENT trials appear
Sign up with your email to follow new studies for NEUROBLASTOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo offers hope for kids with relapsed cancers
Disease control Recruiting nowThis study tests two oral drugs, eflornithine (DFMO) and AMXT 1501, in children and young adults up to age 26 with certain cancers that have come back or not responded to treatment. The cancers include neuroblastoma, brain tumors, and sarcomas. The goal is to find a safe dose and…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New drug combo aims to reignite immune attack on tough childhood cancer
Disease control Recruiting nowThis study tests whether adding an experimental immune-boosting drug (N-803) to standard chemoimmunotherapy can help children and young adults whose neuroblastoma has returned or not responded to treatment. About 54 participants will receive the combination to see if it is safe a…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Promising combo targets Hard-to-Treat childhood cancers
Disease control Recruiting nowThis study is testing a combination of two drugs—a targeted radioactive drug (177Lu-DOTATATE) and a PARP inhibitor (olaparib)—in children and teens aged 3 to 18 with certain solid tumors that have come back or not responded to treatment. The goal is to see if the combination is s…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New quadruple immunotherapy attack on childhood cancer
Disease control Recruiting nowThis phase 2 trial tests a combination of four immune-based treatments for children whose neuroblastoma has returned or not responded to standard care. The therapy includes natural killer cells from a relative, two antibodies (dinutuximab beta and naxitamab), immune-boosting cyto…
Matched conditions: NEUROBLASTOMA RECURRENT
Phase: PHASE2 • Sponsor: Hong Kong Children's Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:10 UTC